Literature DB >> 1161676

Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.

R D Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1161676      PMCID： PMC2495686          DOI： 10.1136/pgmj.51.591.35

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  12 in total

1.  Effects of o,p' DDD on histology and 17-hydroxycorticosteroid output of the dog adrenal cortex.

Authors:  O VILAR; W W TULLNER
Journal:  Endocrinology       Date:  1959-07       Impact factor: 4.736

2.  Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.

Authors:  L Helson; N Wollner; M L Murphy; M K Schwartz
Journal:  Clin Chem       Date:  1971-12       Impact factor: 8.327

3.  Goitrous hypothyroidism induced by amino-glutethimide, anticonvulsant drug.

Authors:  M L Rallison; L F Kumagai; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

4.  Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.

Authors:  T E Temple; D J Jones; G W Liddle; R N Dexter
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

5.  [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].

Authors:  M Philbert; M H Laudat; P Laudat; H Bricaire
Journal:  Ann Endocrinol (Paris)       Date:  1968 Mar-Apr       Impact factor: 2.478

6.  Effects of amino-glutethimide on adrenal function in man.

Authors:  L M Fishman; G W Liddle; D P Island; N Fleischer; O Küchel
Journal:  J Clin Endocrinol Metab       Date:  1967-04       Impact factor: 5.958

7.  Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

Authors:  R Cash; A J Brough; M N Cohen; P S Satoh
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

8.  Clinical therapeutics of adrenal disorders.

Authors:  G W Thorn; D P Lauler
Journal:  Am J Med       Date:  1972-11       Impact factor: 4.965

9.  Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.

Authors:  D E Schteingart; J W Conn
Journal:  J Clin Endocrinol Metab       Date:  1967-12       Impact factor: 5.958

10.  Adrenal cortical carcinoma. Clinical features of 138 patients.

Authors:  A M Hutter; D E Kayhoe
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.